Home > Balance Sheet > CORONA REMEDIES

CORONA REMEDIES
Total Non-Current Assets

    Back to Balance Sheet
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Total Non-Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Total Non-Current Assets ₹857 Cr₹591 Cr₹541 Cr₹299 Cr

What is the latest Total Non-Current Assets ratio of CORONA REMEDIES ?

The latest Total Non-Current Assets ratio of CORONA REMEDIES is ₹857 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Assets
Mar2026₹857 Cr
Mar2025₹591 Cr
Mar2024₹541 Cr
Mar2023₹299 Cr

How is Total Non-Current Assets of CORONA REMEDIES Trending?

Years Total Non-Current Assets % Change
Mar2026 ₹857 Cr
44.98
Mar2025 ₹591 Cr
9.31
Mar2024 ₹541 Cr
80.65
Mar2023 ₹299 Cr -

Compare Total Non-Current Assets of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,890.3 Cr -2.7% 1.8% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-2.7%

1.8%

NA
SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses